Zhejiang Xianju Pharmaceutical Co.,Ltd. (SHE:002332)
China flag China · Delayed Price · Currency is CNY
9.17
+0.04 (0.44%)
Feb 24, 2026, 3:04 PM CST

SHE:002332 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
9,0319,83312,63211,17813,05813,216
Market Cap Growth
-5.68%-22.16%13.01%-14.39%-1.20%46.14%
Enterprise Value
8,0368,69311,20810,04612,82813,835
Last Close Price
9.139.5211.9410.3511.9011.91
PE Ratio
33.1324.7622.4314.9221.0826.20
Forward PE
15.7412.8617.6414.2616.4219.94
PS Ratio
2.522.463.062.553.003.29
PB Ratio
1.501.672.172.032.642.88
P/TBV Ratio
1.741.922.522.383.193.63
P/FCF Ratio
86.6251.4635.0134.2131.9019.69
P/OCF Ratio
29.2524.6721.2118.3519.8516.75
EV/Sales Ratio
2.242.172.722.292.943.44
EV/EBITDA Ratio
11.8810.4113.7311.6014.9716.93
EV/EBIT Ratio
17.9614.0818.5314.8019.0621.62
EV/FCF Ratio
77.0745.5031.0630.7531.3420.62
Debt / Equity Ratio
0.050.010.040.060.150.26
Debt / EBITDA Ratio
0.410.070.270.400.861.44
Debt / FCF Ratio
2.680.310.611.051.811.76
Net Debt / Equity Ratio
-0.17-0.22-0.25-0.25-0.21-0.17
Net Debt / EBITDA Ratio
-1.53-1.58-1.76-1.59-1.20-0.93
Net Debt / FCF Ratio
-9.86-6.92-3.99-4.21-2.51-1.13
Asset Turnover
0.510.570.600.650.640.64
Inventory Turnover
1.481.882.172.072.262.58
Quick Ratio
2.122.942.292.581.831.78
Current Ratio
3.064.203.253.542.572.32
Return on Equity (ROE)
4.18%6.83%9.92%14.29%13.04%13.85%
Return on Assets (ROA)
3.95%5.52%5.51%6.30%6.20%6.32%
Return on Invested Capital (ROIC)
6.84%11.07%12.44%14.45%14.79%14.34%
Return on Capital Employed (ROCE)
7.30%9.90%10.20%11.80%12.60%12.30%
Earnings Yield
3.03%4.04%4.46%6.70%4.74%3.82%
FCF Yield
1.15%1.94%2.86%2.92%3.14%5.08%
Dividend Yield
2.19%3.15%2.51%2.90%1.26%1.26%
Payout Ratio
109.64%75.08%53.24%20.58%27.79%28.22%
Buyback Yield / Dilution
-0.54%-0.51%0.13%-0.00%-7.84%-0.59%
Total Shareholder Return
1.65%2.64%2.65%2.90%-6.58%0.67%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.